News Article

This graph below shows the prescription of GLP-1 medications from shortly after prescription medication Liraglutide was approved for NHS use in specialist weight management services in England to the present day.

While a number of access factors have pushed uptake historically, a combination of heightened awareness and the availability of tirzepatide has pushed adoption significantly. However, based on expenditures, it is estimated the current prescriptions amounts only to 30-40k of the estimated 200k people elegible for NHS treatment.